Microglial inhibitory mechanism of Coenzyme Q10 against Aβ (1-42) induced cognitive dysfunctions: possible behavioral, biochemical, cellular and histopathological alterations
Rationale: Alzheimer’s disease (AD) is a debilitating disease with complex pathophysiology. Amyloid beta (Aβ) (1-42) is a reliable model of AD that recapitulates many aspects of human AD. Objective: The present study has been designed to investigate the neuroprotective potential of Coenzyme Q10 (CoQ...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2015-11-01
|
| Series: | Frontiers in Pharmacology |
| Assuntos: | |
| Acceso en liña: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00268/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|